Aytu BioPharma AYTU reported its Q3 earnings results on Thursday, May 11, 2023 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Aytu BioPharma missed estimated earnings by 206.35%, reporting an EPS of $-1.93 versus an estimate of $-0.63.
Revenue was down $1.47 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.55 which was followed by a 5.78% drop in the share price the next day.
Here's a look at Aytu BioPharma's past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | -1.60 | -3.6 | -7.4 | -8.2 |
| EPS Actual | -2.15 | -1.2 | -9.8 | -5.4 |
| Revenue Estimate | 26.40M | 24.30M | 25.50M | 24.80M |
| Revenue Actual | 26.28M | 27.66M | 27.45M | 24.20M |
To track all earnings releases for Aytu BioPharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.